BodeVet, Inc is a biotechnology and life sciences startup founded in 2017. The company's focus is on promoting animal health and welfare by developing and delivering new treatment solutions to veterinary medical practitioners. Their emphasis on responsiveness, clinical excellence, and innovation is evident as they work on developing novel blood products for use in hemostasis and regenerative medicine. BodeVet, Inc operates at the intersection of biotechnology, life sciences, and retail industries, positioning itself as a key player in the veterinary medical field. While specific information about their headquarters, last investment, and investors is currently unavailable, the company's commitment to developing cutting-edge solutions for animal health presents a promising investment opportunity for venture capital firms seeking to support innovation in the veterinary sector.
There is no investment information
No recent news or press coverage available for BodeVet, Inc.
We care about your data, and we'd love to use cookies make your experience better.
